Researchers at Stanford have developed a method to direct T cell fate toward the T stem cell memory (TSCM) phenotype during ex vivo expansion for adoptive cell transfer (ACT) therapies.
Compressed sensing has revolutionized signal acquisition by enabling high dimensional signals to be measured with remarkable fidelity using a small number of so-called incoherent sensors.